Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Neurochem ; 129(6): 940-54, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24606183

RESUMO

HIF-1α is pivotal for cellular homeostasis in response to cerebral ischemia. Pharmacological inhibition of HIF-1α may reduce secondary brain damage by targeting post-translational mechanisms associated with its proteasomal degradation and nuclear translocation. This study examined the neuroprotective effects of 2-methoxyestradiol (2ME2), the involved HIF-1α-dependent response, and alternative splicing in exon 14 of HIF-1α (HIF-1α∆Ex14) after traumatic brain injury (TBI) in mice. Intraperitoneal 2ME2 administration 30 min after TBI caused a dose-dependent reduction in secondary brain damage after 24 h. 2ME2 was physiologically tolerated, showed no effects on immune cell brain migration, and mitigated trauma-induced brain expression of neuropathologically relevant HIF-1α target genes encoding for Plasminogen activator inhibitor 1 and tumor necrosis factor alpha. Moreover, TBI-induced expression of pro-apoptotic BNIP3 was attenuated by 2ME2 treatment. Alternatively, spliced HIF-1α∆Ex14 was substantially up-regulated from 6 to 48 h after TBI. In vitro, nuclear location and gene transcription activity of HIF-1α∆Ex14 were impaired compared to full-length HIF-1α, but no effects on nuclear translocation of the transcriptional complex partner HIF-1ß were observed. This study demonstrates that 2ME2 confers neuroprotection after TBI. While the role of alternatively spliced HIF-1α∆Ex14 remains elusive, the in vivo data provide evidence that inhibition of a maladaptive HIF-1α-dependent response contributes to the neuroprotective effects of 2ME2. We examined neuroprotective effects of 2-methoxyestradiol (2ME2) and the hypoxia-inducible factor 1-α (HIF-1α) response following traumatic brain injury in mice. Early 2ME2 administration reduced the secondary brain damage and neuronal HIF-1α probably involving ubiquitin proteasome system-mediated degradation. The up-regulation of neuropathological HIF-1α target genes and pro-apoptotic BNIP3 protein was attenuated. We propose that the inhibition of a maladaptive HIF-1α response may contribute to 2ME2-mediated neuroprotection.


Assuntos
Lesões Encefálicas/tratamento farmacológico , Lesões Encefálicas/metabolismo , Estradiol/análogos & derivados , Subunidade alfa do Fator 1 Induzível por Hipóxia/antagonistas & inibidores , Fármacos Neuroprotetores , Processamento Alternativo , Animais , Western Blotting , Isquemia Encefálica/tratamento farmacológico , Isquemia Encefálica/metabolismo , Isquemia Encefálica/patologia , Núcleo Celular/metabolismo , Estradiol/farmacologia , Éxons/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Imuno-Histoquímica , Injeções Intraperitoneais , Masculino , Proteínas de Membrana/biossíntese , Camundongos , Camundongos Endogâmicos C57BL , Proteínas Mitocondriais/biossíntese , Neurônios/metabolismo , Inibidor 1 de Ativador de Plasminogênio/metabolismo , Transporte Proteico , Frações Subcelulares/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Regulação para Cima/genética , Regulação para Cima/fisiologia
2.
J Biol Chem ; 287(42): 35299-35317, 2012 Oct 12.
Artigo em Inglês | MEDLINE | ID: mdl-22915583

RESUMO

The constitutive reverter of eIF2α phosphorylation (CReP)/PPP1r15B targets the catalytic subunit of protein phosphatase 1 (PP1c) to phosphorylated eIF2α (p-eIF2α) to promote its dephosphorylation and translation initiation. Here, we report a novel role and mode of action of CReP. We found that CReP regulates uptake of the pore-forming Staphylococcus aureus α-toxin by epithelial cells. This function was independent of PP1c and translation, although p-eIF2α was involved. The latter accumulated at sites of toxin attack and appeared conjointly with α-toxin in early endosomes. CReP localized to membranes, interacted with phosphomimetic eIF2α, and, upon overexpression, induced and decorated a population of intracellular vesicles, characterized by accumulation of N-(lissamine rhodamine B sulfonyl)phosphatidylethanolamine (N-Rh-PE), a lipid marker of exosomes and intralumenal vesicles of multivesicular bodies. By truncation analysis, we delineated the CReP vesicle induction/association region, which comprises an amphipathic α-helix and is distinct from the PP1c interaction domain. CReP was also required for exocytosis from erythroleukemia cells and thus appears to play a broader role in membrane traffic. In summary, the mammalian traffic machinery co-opts p-eIF2α and CReP, regulators of translation initiation.


Assuntos
Membrana Celular/metabolismo , Endossomos/metabolismo , Células Epiteliais/metabolismo , Fator de Iniciação 2 em Eucariotos/metabolismo , Iniciação Traducional da Cadeia Peptídica/fisiologia , Proteína Fosfatase 1/metabolismo , Animais , Toxinas Bacterianas/metabolismo , Membrana Celular/genética , Endossomos/genética , Células Epiteliais/citologia , Fator de Iniciação 2 em Eucariotos/genética , Humanos , Células K562 , Fosforilação/fisiologia , Proteína Fosfatase 1/genética , Estrutura Secundária de Proteína , Estrutura Terciária de Proteína , Transporte Proteico/fisiologia , Coelhos , Staphylococcus aureus/metabolismo
3.
Biochem Biophys Res Commun ; 385(4): 503-6, 2009 Aug 07.
Artigo em Inglês | MEDLINE | ID: mdl-19497299

RESUMO

Mitogen activated protein kinase (MAPK) p38 has emerged as a survival protein in cells that are attacked by bacterial toxins forming small membrane pores. Activation of p38 by pore forming toxins (PFT) has been attributed to osmotic stress, but here we show that loss of K+ is likely to be the critical parameter. Several lines of evidence support this conclusion: first, osmoprotection did not prevent p38-phosphorylation in alpha-toxin-loaded cells. Second, treatment of cells with a K+ ionophore, or simple incubation in K+-free medium sufficed to cause robust p38-phosphorylation. Third, media containing high [K+] prevented p38-activation by Staphylococcus aureus alpha-toxin, Vibrio cholerae cytolysin (VCC), Streptolysin O (SLO), or Escherichia coli hemolysin (HlyA), but did not impair activation by H2O2. Fourth, potential roles of LPS, TLR4, or calcium-influx were ruled out. Therefore, we propose that PFT trigger the p38 MAPK-pathway by causing loss of cellular K+.


Assuntos
Toxinas Bacterianas/toxicidade , Membrana Celular/efeitos dos fármacos , Células Epiteliais/efeitos dos fármacos , Proteínas Citotóxicas Formadoras de Poros/toxicidade , Potássio/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/biossíntese , Cálcio/metabolismo , Linhagem Celular , Membrana Celular/enzimologia , Ativação Enzimática , Células Epiteliais/enzimologia , Proteínas de Escherichia coli/toxicidade , Proteínas Hemolisinas/toxicidade , Humanos , Fosforilação
4.
Cell Microbiol ; 8(10): 1591-600, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16984414

RESUMO

Staphylococcal alpha-toxin is an archetypal killer protein that homo-oligomerizes in target cells to create small transmembrane pores. The membrane-perforating beta-barrel motif is a conserved attack element of cytolysins of Gram-positive and Gram-negative bacteria. Following the recognition that nucleated cells can survive membrane permeabilization, a profile of abundant transcripts was obtained in transiently perforated keratinocytes. Several immediate early genes were found to be upregulated, reminiscent of the cellular response to growth factors. Cell cycle analyses revealed doubling of S + G2/M phase cells 26 h post toxin treatment. Determination of cell counts uncovered that after an initial drop, numbers increased to exceed the controls after 2 days. A non-lytic alpha-toxin mutant remained without effect. The alpha-toxin pore is too small to allow egress of cytosolic growth factors, and evidence was instead obtained for growth signalling via the epidermal growth factor receptor (EGFR). Inhibition of the EGFR or of EGFR-proligand-processing blocked the mitogenic effect of alpha-toxin. Western blots with phospho-specific antibodies revealed activation of the EGFR, and of the adapter protein Shc. Immediate early response and proliferation upon transient plasma membrane pore formation by bacterial toxins may represent a novel facet of the complex interaction between pathogen and host.


Assuntos
Toxinas Bacterianas , Receptores ErbB/metabolismo , Proteínas Hemolisinas , Queratinócitos/metabolismo , Staphylococcus aureus/fisiologia , Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Western Blotting , Ciclo Celular , Linhagem Celular , Linhagem Celular Transformada , Proliferação de Células , Citotoxinas/metabolismo , Citometria de Fluxo , Imunofluorescência , Perfilação da Expressão Gênica , Humanos , Queratinócitos/citologia , Queratinócitos/microbiologia , Mitógenos/farmacologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Proteínas Adaptadoras da Sinalização Shc , Transdução de Sinais , Proteína 1 de Transformação que Contém Domínio 2 de Homologia de Src , Transfecção
5.
Biochem Biophys Res Commun ; 344(4): 1128-34, 2006 Jun 16.
Artigo em Inglês | MEDLINE | ID: mdl-16643845

RESUMO

Following the observation that cells are able to recover from membrane lesions incurred by Staphylococcus aureus alpha-toxin and streptolysin O (SLO), we investigated the role of p38 in this process. p38 phosphorylation occurred in response to attack by both toxins, commencing within minutes after toxin treatment and waning after several hours. While SLO reportedly activates p38 via ASK1 and ROS, we show that this pathway does not play a major role for p38 induction in alpha-toxin-treated cells. Strikingly divergent effects of p38 blockade were noted depending on the toxin employed. In the case of alpha-toxin, inhibition of p38 within the time frame of its activation led to disruption of the recovery process and to cell death. In contrast, blockade of p38 in SLO permeabilized cells did not affect the capacity of the cells to replenish their ATP stores.


Assuntos
Toxinas Bacterianas/farmacologia , Membrana Celular/metabolismo , Queratinócitos/efeitos dos fármacos , Queratinócitos/enzimologia , Staphylococcus aureus , Estreptolisinas/farmacologia , Proteínas Quinases p38 Ativadas por Mitógeno/fisiologia , Trifosfato de Adenosina/metabolismo , Proteínas de Bactérias/farmacologia , Permeabilidade da Membrana Celular , Células Cultivadas , Ativação Enzimática , Proteínas Hemolisinas , Humanos , MAP Quinase Quinase Quinase 5/antagonistas & inibidores , MAP Quinase Quinase Quinase 5/metabolismo , Fosforilação , Proteínas Tirosina Quinases/antagonistas & inibidores , Proteínas Tirosina Quinases/metabolismo , Proteínas Proto-Oncogênicas/antagonistas & inibidores , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/antagonistas & inibidores , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA